Pfizer/BioNTech Submitted Data to US FDA to Support Covid-19 Vaccine Booster
Pfizer and BioNTech have announced, they have submitted the data of the phase 1 trials of the vaccine to the US FDA for the purpose of supporting the evaluation of a third dose or the booster dose of the novel corona virus vaccine for getting the license in the future, and the data of these […]
Continue Reading